BioSpace News Archive

GenomOncology announced that the GenomOncology Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease detection.

Emmaus Life Sciences, Inc. announced the recent engagement of Acorn Management Partners, LLC to provided professional relations and consulting services to build investor awareness of Emmaus.

The global medical foods market size is expected to reach USD 33.85 Billion in 2030 and register a revenue CAGR of 5.4% over the forecast period, according to latest report by Reports and Data.

Selux Diagnostics, Inc. announced that it has been awarded an additional $8.0 million from the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response.

The global dermatology market size reached USD 1.11 Billion in 2021 and is expected to register a revenue CAGR of 6.9% during the forecast period, according to latest analysis by Emergen Research.

The global dialysis market size reached USD 94.90 Billion in 2021 and is expected to register a revenue CAGR of 4.68% during the forecast period, according to a latest analysis by Emergen Research.

VisionHealth and Boehringer Ingelheim will cooperate on the Kata® app for therapy support in asthma and chronic obstructive pulmonary disease (COPD).

A team at NYU Langone Health successfully transplanted two genetically engineered pig hearts into recently deceased humans in June and July, marking the latest advances toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease.

Allogene Therapeutics, Inc. announced the appointment of Stephen L. Mayo, Ph.D., a world renowned expert in computational protein design, to the company’s Board of Directors.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Deborah Telman will join the company as Executive Vice President, Corporate Affairs and General Counsel, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.